Nuveen’s Theravance Biopharma TBPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.07M Buy
127,678
+38,690
+43% +$684K ﹤0.01% 2266
2025
Q4
$1.66M Sell
88,988
-3,226
-3% -$53.5K ﹤0.01% 2366
2025
Q3
$1.35M Sell
92,214
-28,374
-24% -$359K ﹤0.01% 2478
2025
Q2
$1.33M Sell
120,588
-254,364
-68% -$2.47M ﹤0.01% 2473
2025
Q1
$3.35M Sell
374,952
-120,775
-24% -$1.12M ﹤0.01% 2122
2024
Q4
$4.66M Buy
495,727
+48,635
+11% +$443K ﹤0.01% 2015
2024
Q3
$3.6M Buy
447,092
+104,377
+30% +$904K ﹤0.01% 2138
2024
Q2
$2.91M Buy
342,715
+182,897
+114% +$1.65M ﹤0.01% 2201
2024
Q1
$1.43M Hold
159,818
﹤0.01% 2551
2023
Q4
$1.8M Sell
159,818
-4,770
-3% -$48K ﹤0.01% 2459
2023
Q3
$1.42M Buy
164,588
+7,259
+5% +$70.1K ﹤0.01% 2433
2023
Q2
$1.63M Buy
157,329
+2,819
+2% +$31.1K ﹤0.01% 2441
2023
Q1
$1.68M Sell
154,510
-97,537
-39% -$1.03M ﹤0.01% 2409
2022
Q4
$2.83M Buy
252,047
+75,874
+43% +$797K ﹤0.01% 2229
2022
Q3
$1.79M Sell
176,173
-63,989
-27% -$600K ﹤0.01% 2454
2022
Q2
$2.18M Buy
240,162
+53,256
+28% +$491K ﹤0.01% 2399
2022
Q1
$1.81M Buy
186,906
+22,116
+13% +$217K ﹤0.01% 2546
2021
Q4
$1.65M Sell
164,790
-11,927
-7% -$104K ﹤0.01% 2658
2021
Q3
$1.26M Sell
176,717
-10,955
-6% -$123K ﹤0.01% 2897
2021
Q2
$2.73M Sell
187,672
-4,215
-2% -$79.2K ﹤0.01% 2561
2021
Q1
$3.92M Buy
191,887
+1,727
+0.9% +$32.8K ﹤0.01% 2287
2020
Q4
$3.38M Sell
190,160
-19,473
-9% -$350K ﹤0.01% 2256
2020
Q3
$3.1M Sell
209,633
-6,020
-3% -$113K ﹤0.01% 2162
2020
Q2
$4.53M Sell
215,653
-86,492
-29% -$2.22M ﹤0.01% 1952
2020
Q1
$6.98M Buy
302,145
+30,194
+11% +$756K ﹤0.01% 1515
2019
Q4
$7.04M Sell
271,951
-5,840
-2% -$113K ﹤0.01% 1804
2019
Q3
$5.41M Buy
277,791
+56,699
+26% +$1.15M ﹤0.01% 1912
2019
Q2
$3.61M Buy
+221,092
New +$4.48M ﹤0.01% 2161

Other funds holding TBPH